Please login to the form below
Bravely Bedrock
This page shows the latest Bravely Bedrock news and features for those working in and with pharma, biotech and healthcare.
Latest from PMHub
-
Medical affairs - a strategic function for scientific engagement
The shift in dynamics between medical affairs and commercial teams. David Youds, CEO, Bedrock Group. ... David Youds, CEO, Bedrock Group.
-
Bedrock strengthens its senior team
Bedrock Healthcare Communications has strengthened its management team with the recruitment of a senior role. ... This appointment underpins Bedrock’s commitment to its values – to be recognised as THE creative medical communications agency and to
-
Meg Morgan wins top recognition award
year who has consistently lived the Bedrock’s values and in doing so has achieved outstanding results. ... growth. Meg lives the Bedrock Values ‘Exceeding Expectations’, ‘Bravely Bedrock’ and ‘Freethinking’ and is passionate about helping
-
Bedrock creates waves
The Bedrock team were awash with ideas at their summer watersports and BBQ event. ... All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming the infamous Ringo Rides!
More from PMHub
Approximately 4 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Live Webinar: Navigating the Nuances of Europe's MedTech Industry
- Why project managers are key to creating quality content
- Pfizer and BioNTech sign $3.2bn COVID-19 vaccine supply agreement with US government
- EMA grants Bavarian Nordic access to PRIME scheme for RSV vaccine candidate
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- NICE issues final appraisal recommending LEO Pharma’s Adtralza for moderate-to-severe atopic dermatitis
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- A creative awakening – how pharma is bringing innovation to the patient journey
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Pfizer, Mylan move ahead with generics merger and spin-out
PMHub
Viseven
Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
